The study was conducted on a cohort of 6004 AF-naïve individuals aged 70-90, and 47.5% were females. The median NT-proBNP level was 15 pmol/L [interquartile range: 9-28], corresponding to 125 pg/mL [interquartile range: 76-233]...
Most Recent Articles
Coordinated Intervention Increases Evidence-Based Therapies for Adults with Type 2 Diabetes and Cardiovascular Disease
The study was a cluster randomized clinical trial conducted across 43 US cardiology clinics from July 2019 through May 2022, with a follow-up period through December 2022. The trial enrolled 1049 participants, of which 459 were...
Clopidogrel vs. Aspirin for Long-term Maintenance After PCI: Cardiovascular Outcomes in Patients With and Without Diabetes
The study investigated the efficacy and safety of clopidogrel versus aspirin as long-term maintenance therapy after dual antiplatelet therapy for coronary stenting in patients with and without diabetes. The researchers conducted...
VISUALIZED: FFRCT Analysis Reveals Significant Benefits of Icosapent Ethyl in Patients with Atherosclerosis and Elevated Triglycerides
Read further: FFRCT Analysis Reveals Significant Benefits of Icosapent Ethyl in Patients with Atherosclerosis and Elevated Triglycerides
FFRCT Analysis Reveals Significant Benefits of Icosapent Ethyl in Patients with Atherosclerosis and Elevated Triglycerides
The EVAPORATE trial enrolled 80 patients with moderate to high-risk atherosclerosis and persistent elevated triglycerides despite statin therapy. The trial demonstrated that IPE significantly reduced plaque volume and had an...